Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1
IntroductionExtracorporeal photopheresis (ECP) is an immunomodulatory treatment option for different T cell-mediated diseases such as cutaneous T cell lymphoma (CTCL) and chronic graft-versus-host disease (GvHD). While in CTCL the polarization of T cells is shifted towards T helper cells type 1 (TH1...
Saved in:
| Main Authors: | Lukas Heger, Carola Berking, Holger Hackstein |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1646421/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01) -
Extracorporeal photopheresis in stiff person syndrome
by: Yandy Marx Castillo-Aleman, et al.
Published: (2024-12-01) -
Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01) -
The role of extracellular vesicles in chronic lung allograft dysfunction and response to extracorporeal photopheresis
by: Rachel E. Crossland, et al.
Published: (2025-08-01) -
OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
by: A. P. Faenko, et al.
Published: (2018-04-01)